D'Orazio & Associates’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9,989
| Closed | -$220K | – | 261 |
|
|
2024
Q4 | $220K | Sell |
9,989
-1,034
| -9% | -$22.8K | 0.03% | 202 |
|
|
2024
Q3 | $199K | Buy |
+11,023
| New | +$199K | 0.03% | 221 |
|
|
2020
Q1 | – | Sell |
-18
| Closed | – | – | 360 |
|
|
2019
Q4 | $0 | Hold |
18
| – | – | ﹤0.01% | 359 |
|
|
2019
Q3 | $0 | Sell |
18
-320
| -95% | – | ﹤0.01% | 377 |
|
|
2019
Q2 | $3K | Hold |
338
| – | – | ﹤0.01% | 297 |
|
|
2019
Q1 | $5K | Hold |
338
| – | – | ﹤0.01% | 280 |
|
|
2018
Q4 | $5K | Hold |
338
| – | – | ﹤0.01% | 248 |
|
|
2018
Q3 | $7K | Hold |
338
| – | – | ﹤0.01% | 228 |
|
|
2018
Q2 | $8K | Hold |
338
| – | – | ﹤0.01% | 213 |
|
|
2018
Q1 | $6K | Hold |
338
| – | – | ﹤0.01% | 230 |
|
|
2017
Q4 | $6K | Sell |
338
-201
| -37% | -$3.57K | ﹤0.01% | 258 |
|
|
2017
Q3 | $9K | Hold |
539
| – | – | ﹤0.01% | 203 |
|
|
2017
Q2 | $18K | Buy |
539
+201
| +59% | +$6.71K | 0.01% | 193 |
|
|
2017
Q1 | $11K | Hold |
338
| – | – | ﹤0.01% | 216 |
|
|
2016
Q4 | $12K | Hold |
338
| – | – | ﹤0.01% | 191 |
|
|
2016
Q3 | $15K | Hold |
338
| – | – | 0.01% | 180 |
|
|
2016
Q2 | $17K | Hold |
338
| – | – | 0.01% | 183 |
|
|
2016
Q1 | $18K | Hold |
338
| – | – | 0.01% | 182 |
|
|
2015
Q4 | $22K | Hold |
338
| – | – | 0.01% | 146 |
|
|
2015
Q3 | $20K | Hold |
338
| – | – | 0.01% | 147 |
|
|
2015
Q2 | $20K | Hold |
338
| – | – | 0.01% | 144 |
|
|
2015
Q1 | $21K | Hold |
338
| – | – | 0.02% | 149 |
|
|
2014
Q4 | $19K | Hold |
338
| – | – | 0.01% | 142 |
|
|
2014
Q3 | $18K | Hold |
338
| – | – | 0.01% | 145 |
|
|
2014
Q2 | $18K | Hold |
338
| – | – | 0.01% | 147 |
|
|
2014
Q1 | $18K | Hold |
338
| – | – | 0.01% | 141 |
|
|
2013
Q4 | $14K | Buy |
+338
| New | +$14K | 0.01% | 148 |
|